Impact of PIK3CAgain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapies

MLA

Bettazova, Nardjas, et al. “Impact of PIK3CAgain and PTEN Loss on Mantle Cell Lymphoma Biology and Sensitivity to Targeted Therapies.” Blood Advances, vol. 8, no. 20, Oct. 2024, pp. 5279–89. EBSCOhost, https://doi.org/10.1182/bloodadvances.2024013205.

APA

Bettazova, N., Senavova, J., Kupcova, K., Sovilj, D., Rajmonova, A., Andera, L., Svobodova, K., Berkova, A., Zemanova, Z., Daumova, L., Herman, V., Dolníkova, A., Davis, R. E., Trneny, M., Klener, P., & Havranek, O. (2024). Impact of PIK3CAgain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapies. Blood Advances, 8(20), 5279–5289. https://doi.org/10.1182/bloodadvances.2024013205

Chicago

Bettazova, Nardjas, Jana Senavova, Kristyna Kupcova, Dana Sovilj, Anezka Rajmonova, Ladislav Andera, Karla Svobodova, et al. 2024. “Impact of PIK3CAgain and PTEN Loss on Mantle Cell Lymphoma Biology and Sensitivity to Targeted Therapies.” Blood Advances 8 (20): 5279–89. doi:10.1182/bloodadvances.2024013205.